Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10101178 | 0.90 | PIK3CB (0.42) | PIK3CBENTPD5 | |
| SCHEMBL10101368 | 0.89 | PIK3CB (0.43) | PIK3CBENTPD5 | |
| SCHEMBL10101182 | 0.87 | PIK3CB (0.43) | PIK3CBENTPD5 | |
| SCHEMBL10101170 | 0.87 | PIK3CB (0.41) | PIK3CBENTPD5 | |
| SCHEMBL10101157 | 0.82 | PIK3CB (0.57) | PIK3CBENTPD5 | |
| SCHEMBL10101159 | 0.79 | PIK3CB (0.45) | PIK3CBENTPD5 | |
| SCHEMBL10101133 | 0.77 | PIK3CB (0.47) | PIK3CBENTPD5 | |
| SCHEMBL10101179 | 0.77 | PIK3CB (0.43) | PIK3CBENTPD5 | |
| SCHEMBL10101171 | 0.76 | PIK3CB (0.42) | PIK3CBENTPD5 | |
| SCHEMBL10101172 | 0.76 | PIK3CB (0.43) | PIK3CBENTPD5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8101605-B2 | SHIP1 modulators and methods related thereto | AQUINOX PHARMACEUTICALS INC. (CA) | 2012-01-24 | — | — | US | disclosed |
| US-20110136802-A1 | SHIP1 MODULATORS AND METHODS RELATED THERETO | AQUINOX PHARMACEUTICALS INC. (CA) | 2011-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110136802-A1 | SHIP1 MODULATORS AND METHODS RELATED THERETO | PPM1D, PTPRO, PPM1G | PIK3CB 98/4885ENTPD5 750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.